Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.
For the
three
months ended in Jun. 2026,
Mouwasat Medical Services Co paid﷼0 Mil more to buy back shares than it received from issuing new shares.
It spent﷼5 Mil paying down its debt.
It paid﷼0 Mil more to buy back preferred shares than it received from issuing preferred shares.
It received﷼0 Mil from paying cash dividends to shareholders.
It spent﷼237 Mil on other financial activities.
In all, Mouwasat Medical Services Cospent﷼242 Mil on financial activities for the
three
months ended in Jun. 2026.
Mouwasat Medical Services Co (SAU:4002) Cash Flow from Financing Explanation
Cash from financing contains six items:
1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.
Mouwasat Medical Services Co's issuance of stock for the
three
months ended in Jun. 2026 was ﷼0 Mil.
2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.
Mouwasat Medical Services Co's repurchase of stock for the
three
months ended in Jun. 2026 was ﷼0 Mil.
3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Mouwasat Medical Services Co's net issuance of debt for the
three
months ended in Jun. 2026 was ﷼-5 Mil.
Mouwasat Medical Services Co spent﷼5 Mil paying down its debt.
4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.
Mouwasat Medical Services Co's net issuance of preferred for the
three
months ended in Jun. 2026 was ﷼0 Mil.
Mouwasat Medical Services Co paid﷼0 Mil more to buy back preferred shares than it received from issuing preferred shares.
5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.
Mouwasat Medical Services Co's cash flow for dividends for the
three
months ended in Jun. 2026 was ﷼0 Mil.
Mouwasat Medical Services Co received﷼0 Mil from paying cash dividends to shareholders.
6. Other Financing:
Money spent or earned by company from other financial activities.
Mouwasat Medical Services Co's other financing for the
three
months ended in Jun. 2026 was ﷼-237 Mil.
Mouwasat Medical Services Co spent﷼237 Mil on other financial activities.
Mouwasat Medical Services Co Cash Flow from Financing Related Terms
Mouwasat Medical Services Co Cash Flow from Financing Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mouwasat Medical Services Co Cash Flow from Financing Chart
Mouwasat Medical Services Co Cash Flow from Financing Calculation
This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.
Mouwasat Medical Services Co's Cash from Financing for the fiscal year that ended in Dec. 2025 is calculated as:
Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼-277 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Cash Flow from Financing of ﷼-277 Mil mean?
Mouwasat Medical Services Co (SAU:4002) has a Cash Flow from Financing of ﷼-277 Mil as of Jun. 2026. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Mouwasat Medical Services Co and its competitors.
Is Mouwasat Medical Services Co's Cash Flow from Financing too high?
Mouwasat Medical Services Co's current Cash Flow from Financing is ﷼-277 Mil. Overall, Mouwasat Medical Services Co has a GF Score™ of 100/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mouwasat Medical Services Co's Cash Flow from Financing compare to HCA and THC?
Mouwasat Medical Services Co's Cash Flow from Financing of ﷼-277 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Mouwasat Medical Services Co and its competitors. Mouwasat Medical Services Co's current Cash Flow from Financing is ﷼-277 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mouwasat Medical Services Co stock overvalued right now?
Based on GuruFocus' analysis, Mouwasat Medical Services Co (SAU:4002) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼102.23, compared to a current price of ﷼64.85 — trading 36.6% below its estimated fair value. The current Cash Flow from Financing is ﷼-277 Mil. Mouwasat Medical Services Co's overall GF Score™ is 100/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Mouwasat Medical Services Co (SAU:4002), the current Cash Flow from Financing is ﷼-277 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mouwasat Medical Services Co (SAU:4002) Overvalued in 2026?
Based on GuruFocus' analysis, Mouwasat Medical Services Co stock appears to be undervalued.
The current stock price of ﷼64.85 is trading 36.6% below its estimated GF Value™ of ﷼102.23.
GuruFocus considers Mouwasat Medical Services Co to be Significantly Undervalued.
Key valuation signals for SAU:4002:
Cash Flow from Financing: ﷼-277 Mil
GF Value™: ﷼102.23 vs. price of ﷼64.85 (36.6% below fair value)
No single metric tells the full story. See the SAU:4002 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mouwasat Medical Services Co is engaged in the acquisition, management, operation, and maintenance of hospitals, medical centers, drug stores, pharmacies, and wholesale of medical equipment and drugs. The company also operates skin care centers that offer clinical and cosmetic dermatology, aesthetic and reconstructive plastic surgery, weight reduction, and esthetician services. It operates in two segments Medical Services segment and Pharmaceuticals out of which the Medical Services segment derives the majority of revenue. The Medical Services segment includes Inpatient and outpatient services. The company provides specialized centers: Eye Center, Robotic Surgeries Center, Diabetes Center, Fertility Unit, Cardiology Center, Stroke Unit, Long Term Care Center, Obesity Center, and others.
100GF Score
Get the complete analysis for SAU:4002
Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4002 has been successfully added to your 
